2014, Number 610
<< Back Next >>
Rev Med Cos Cen 2014; 71 (610)
Sindrome de Stevens-Johnson y necrólisis epidérmica tóxica
Barrantes MR, Espinoza MK
Language: Spanish
References: 10
Page: 305-308
PDF size: 166.56 Kb.
ABSTRACT
Stevens-Johnson syndrome and
toxic epidermal necrolysis is a
disorder of immune complexmediated
hypersensitivity that is
a severe expression of erythema
multiforme, typically involving
the skin, oral cavity, eyes and
genitals. It is caused by many
drugs, infections and malignant
tumors. Its pathogenesis is
still partially unknown, and
no specific treatment has been
shown to be clearly beneficial,
therefore, the best treatment is
early diagnosis, withdrawal of
the suspect drug and support
therapy.
REFERENCES
Jean-Aan M, Tay Y, Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children, Journal of the American Academy of Dermatology, Volume 62, Issue 1, January 2010, 54-60.
Laguna C, Martín B, Torrijos A, García-Melgares M, Febrer I, Síndrome de Stevens-Johnson y necrólisis epidérmica tóxica: experiencia clínica y revisión de la literatura especializada, Actas Dermo-Sifiliográficas, Volume 97, Issue 3, April 2006, 177-185.
Martínez-Pérez J, Caldevilla- Bernardo D, Perales-Pardo R, Pérez- Gómez F. Síndrome de Stevens- Johnson, a propósito de un caso de fiebre y erupción cutánea. Semergen. 2012; 38:549.
Roujeau J Epidermal necrolysis (Steven-Johnson syndrome and toxic epidermal necrolysis): Historical considerations. DERMATOLOGICA SINICA 31 (2013) 169e174.
Sasankoti Mohan R, Verma S, Gill N, Tyagi K. Stevens–Johnson syndrome: An illustrative report of a case.Indian Journal of Dentistry - June 2013, Vol. 4, Issue 2, 105-109.
Su S, Chung W, Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis. Dermatologica Sinica - December 2013 Vol. 31, Issue 4, 175-180.
Suenaga H, Saijo H, Hoshi K, Mori Y, Takato T, Diclofenac sodium induced Stevens–Johnson syndrome in a hospitalized patient during treatment of splenic injury and mandibular fracture, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, Available online 31 July 2013.
Tremblayemail L, Pineton de Cham brun G, De Vroey B, Lavogiez C, Delaporte E, Colombel J, Cortot A. Stevens–Johnson syndrome with sulfasalazine treatment: Report of two cases. Journal of Crohn’s and Colitis Volume 5, Issue 5 , 2011, 457-460.
Valeyrie-Allanore L, Ingen-Housz- Oro S, Chosidow O, Wolkenstein P, 308 REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA French referral center management of Stevens–Johnson syndrome/toxic epidermal necrolysis, Dermatologica Sinica, Volume 31, Issue 4, 2013, 191-195.
Weinand C, Xu W, Perbix W, Lefering R, Maegele M, Rathert M, Spilker G, 27 years of a single burn centre experience with Stevens–Johnson syndrome and toxic epidermal necrolysis: Analysis of mortality risk for causative agents, Burns, Volume 39, Issue 7, November 2013, 1449-1455.